Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Clinical Classification of Myelofibrosis with Myeloid Metaplasia (MMM): Cluster Analysis of 861 Patients Enrolled into a Nationwide Prospective Registry (RIMM).

M. Marchetti, C. Rognoni, R. Pastorino, R. Bellazzi, P. Magni, S. Quaglini, G. Bergamaschi, R. Invernizzi, U. Magrini, M. Massa, V. Rosti, G. Viarengo, Giovanni Barosi, on Behalf of the Researchers of the Italian Registry of Myelofibrosis

Blood (2005) 106 (11): 2579.

https://doi.org/10.1182/blood.V106.11.2579.2579

Published: 2005

Journal Articles

Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors

V Rosti, G Bergamaschi, C Lucotti, M Danova, C Carlo-Stella, F Locatelli, L Tonon, G Mazzini, M Cazzola

Blood (1995) 86 (9): 3387–3393.

https://doi.org/10.1182/blood.V86.9.3387.bloodjournal8693387

Published: 1995

Journal Articles

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial [see comments]

M Cazzola, L Ponchio, Y Beguin, V Rosti, G Bergamaschi, NL Liberato, V Fregoni, G Nalli, G Barosi, E Ascari

Blood (1992) 79 (1): 29–37.

https://doi.org/10.1182/blood.V79.1.29.29

Published: 1992

Journal Articles

Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects

M Cazzola, G Bergamaschi, L Dezza, P Arosio

Blood (1990) 75 (10): 1903–1919.

https://doi.org/10.1182/blood.V75.10.1903.1903

Published: 1990

Journal Articles

Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM)

C Carlo-Stella, M Cazzola, A Ganser, G Bergamaschi, P Pedrazzoli, D Hoelzer, E Ascari

Blood (1988) 72 (4): 1293–1299.

https://doi.org/10.1182/blood.V72.4.1293.1293

Published: 1988

Journal Articles

Biologic and clinical significance of red cell ferritin

M Cazzola, L Dezza, G Bergamaschi, G Barosi, V Bellotti, D Caldera, MM Ciriello, S Quaglini, P Arosio, E Ascari

Blood (1983) 62 (5): 1078–1087.

https://doi.org/10.1182/blood.V62.5.1078.1078

Published: 1983

NARROW

Clinical Classification of Myelofibrosis with Myeloid Metaplasia (MMM): Cluster Analysis of 861 Patients Enrolled into a Nationwide Prospective Registry (RIMM).

Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial [see comments]

Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects

Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM)

Biologic and clinical significance of red cell ferritin

Email alerts

ASH Publications

American Society of Hematology

Clinical Classification of Myelofibrosis with Myeloid Metaplasia (MMM): Cluster Analysis of 861 Patients Enrolled into a Nationwide Prospective Registry (RIMM).

Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial [see comments]

Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects

Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM)

Biologic and clinical significance of red cell ferritin

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only